摘要
目的观察固本抑瘤Ⅱ号配合化学药物动脉灌注治疗原发性肝癌的疗效。方法将62例原发性肝癌患者随机分为治疗组(予固本抑瘤Ⅱ号配合化学药物动脉灌注)32例、对照组(予化学药物动脉灌注)30例,观察患者生活质量、化疗毒副反应,以及近、远期疗效。结果治疗组的稳定率为93.8%,1年生存率为78.1%、2年生存率为56.2%,都明显高于对照组。治疗组可缓解化疗药物的毒副反应,保护肝脏功能,改善患者的生活质量。结论固本抑瘤Ⅱ号有明显的减毒增效作用,固本抑瘤Ⅱ号配合化学药物动脉灌注治疗原发性肝癌有较好的疗效。
Objective To observe the curative effect of Gubenyiliu Formula Ⅱ combined with the artery perfusion of chemical drugs on primary liver cancer. Method To divide randomly 62 cases of primary liver cancer into the treatment group （n=32, given the arlery perfusion of Gubenyiliu Formula Ⅱ combined with chemical drugs） and the control group （n=30, given the artery perfusion of chemical drugs only）.The life quality, side and toxic effects of chemical therapy and short or long-term curative effects were observed. Result In the treatment group the stable rate of the disease was 93.7 %, the survival rate of one year was 78.1%, and that of two years was 56.2 %. The result of the treatment group was better than that of the control group, meanwhile, the side and toxic effects of chemical drugs was relieved, the liver function was protected and the life quality of the patient was improved. Conclusion Gubenyiliu Formula Ⅱ has a significant toxic-relieving effect and synergism. The therapy combined Gubenyiliu Formula Ⅱ with the artery perfusion of chemical drugs has a better curative effect on primary liver cancer.
出处
《北京中医药大学学报（中医临床版）》
2006年第3期9-11,共3页
Journal of Beijing University of Traditional Chinese Medicine
关键词
固本抑瘤Ⅱ号
化学药物
动脉灌注
原发性肝癌
Gubenyiliu Formula Ⅱ
chemical drugs
artery perfusion
primary liver cancer
